Chemical Component Summary

Name5-FLUOROURACIL
Identifiers5-fluoro-1H-pyrimidine-2,4-dione
FormulaC4 H3 F N2 O2
Molecular Weight130.08
TypeNON-POLYMER
Isomeric SMILESFC1=CNC(=O)NC1=O
InChIInChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
InChIKeyGHASVSINZRGABV-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count12
Chiral Atom Count0
Bond Count12
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB00544 
NameFluorouracil
Groupsapproved
DescriptionA pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid.
Synonyms
  • Fluorouracilo
  • Fluorouracilum
  • Fluoro Uracil
  • Fluouracil
  • 5-Fluorouracil
Brand Names
  • Fluorouracil Injection USP
  • Adrucil Inj 50mg/ml
  • Fluorouracil Injection
  • Actikerall
  • Efudex
IndicationFor the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in the palliative management of some types of cancer, including colon, esophageal, gastric, rectum, breast, biliary tract, stomach, head and neck, cervical, pancreas, renal cell, and carcinoid.
Categories
  • Antimetabolites
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • BCRP/ABCG2 Substrates
  • Cardiotoxic antineoplastic agents
ATC-Code
  • L01BC52
  • L01BC02
CAS number51-21-8

Drug Targets

NameTarget SequencePharmacological ActionActions
Thymidylate synthaseMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDR...unknownother/unknown
DNA-unknownincorporation into and destabilization
RNA-unknownincorporation into and destabilization
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknowninhibitor
Cytochrome P450 1A2MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDBIKHIN01
PubChem5281053
PubChem3385
ChEBICHEBI:46345
ChEMBLCHEMBL185
PharosCHEMBL185